FDA approves Bavarian Nordic’s freeze-dried mpox and smallpox vaccine
The US Food and Drug Administration (FDA) has approved the freeze-dried formulation of Bavarian Nordic’s smallpox and mpox vaccine in…
All articles by Robert Barrie
Robert Barrie
Robert Barrie is a news and features reporter for Pharmaceutical Technology and Medical Device Network. Robert holds a BSc in Neuroscience and holds interests in neurological devices, infectious diseases, and company investment such as initial public offerings (IPOs). Contact Rob
-
-
Sanofi’s Qfitlia approved by FDA as first haemophilia therapy for all patients
Sanofi has won US Food and Drug Administration (FDA) approval for haemophilia treatment Qfitlia (fitusiran), as the company aims to…
-
Blockbuster potential drugs ruled the 2024 pipeline with 53% rise over 2023
The number of late-stage drug candidates with peak sales forecasts exceeding $1bn rose significantly last year, buoyed in part by…
-
FDA fast tracks Sanofi’s mRNA vaccine for chlamydia
The US Food and Drug Administration (FDA) has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention…
-
Novo Nordisk earmarks $2bn for Chinese “triple G” weight loss shot
Novo Nordisk has acquired the global rights to China-based United Laboratories’ triple-agonist weight-loss and diabetes drug in a deal worth…
-
Valneva outlays 40,000 vaccines to Réunion amidst chikungunya surge
Valneva will provide 40,000 doses of its chikungunya vaccine Ixchiq to French overseas territory La Réunion as part of efforts…
-
Global funding cuts reversing decades of tuberculosis progress, WHO says
Ahead of World Tuberculosis Day on 24 March, the World Health Organization (WHO) has said that cuts in global funding…
-
Sanofi outlays $1.9bn to purchase Dren Bio’s bispecific antibody
Sanofi is continuing its immunology pipeline push with an agreement to acquire Dren Bio’s bispecific antibody DR-0201 in a deal…
-
Sacklers to pay up to $7bn in Purdue Pharma’s opioid settlement plan
Purdue Pharma has filed a new bankruptcy plan that details how the funds will be allocated and the proportion paid…
-
Curevo procures $110m and former-GSK exec for shingles vaccine candidate
Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive…